Too Beauty Medical Technology (02576.HK) plans to implement full circulation of H shares.

Zhijing Financial App News, TaiMei Medical Technology (02576.HK) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of the full circulation of the company's H shares in China (CSRC filing). According to the CSRC filing, the company has applied on behalf of several shareholders to convert a total of 363 million domestic shares of the company (domestic shares) held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (conversion and listing). Once all relevant regulatory authorities (including the CSRC and the Hong Kong Stock Exchange) obtain all filings and/or approvals and comply with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares, which will then be listed and traded on the main board of the Hong Kong Stock Exchange. According to the company's articles of association, the company is not required to convene a shareholders' meeting to approve the conversion and listing.